Skip to main content
. 2014 Oct 28;112(1):103–111. doi: 10.1038/bjc.2014.556

Figure 4.

Figure 4

Progression-free and overall survival according to EGFR expression in HER2-positive metastatic breast cancer. EGFR overexpression defined as 3+ (A) and 2+ or more (B) were not associated with progression-free survival. EGFR overexpression defined as 3+ (C) and 2+ or more (D) tends to be associated with decreased overall survival.